Form D · Other Health Care
ByHeart, Inc.
New York, NY · CIK 0001780950
Offering snapshot reported May 7, 2026 · SEC filing
- Reported sold
- $95.5M Offering amount: $95.5M
- Investors reported
- 46 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 28, 2024 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 7, 2026 | Amendment | $95,493,537 | $0vs May 13, 2025 | 46 | SEC filing |
| Mar 31, 2026 | Amendment | $72,177,578 | $0vs Mar 27, 2025 | 49 | SEC filing |
| May 13, 2025 | Amendment | $95,493,537 | $15,446,904vs Apr 8, 2024 | 46 | SEC filing |
| Mar 27, 2025 | Initial | $72,177,578 | No comparison | 49 | SEC filing |
| Apr 8, 2024 | Initial | $80,046,633 | No comparison | 4 | SEC filing |
| Jan 13, 2023 | Initial | $29,639,049 | No comparison | 14 | SEC filing |
| Jul 29, 2021 | Amendment | $62,199,472 | No comparison | Not reported | SEC filing |
| Jul 27, 2021 | Initial | $60,589,470 | No comparison | Not reported | SEC filing |
| Apr 1, 2020 | Initial | $96,885,369 | No comparison | 99 | SEC filing |
| Jun 27, 2019 | Initial | $22,000,000 | No comparison | 49 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-509961
13(a) and 13(c) incl. outstanding warrants to purchase Preferred Stock issued in connection with the completed offering, which may never be exercised; 13(a) and (b) incl. the conversion of outstanding principal and accrued interest of outstanding debt.
Source: Form D, filed May 7, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Elizabeth Abrams | Director |
| Elias Aoukar | Executive |
| James E. Bauersmith | Executive |
| Arie Belldegrun | Director |
| Ron Belldegrun | Director, Executive |
| Joshua Bradley | Director |
| Tommy Burke | Director |
| Mia B. Funt | Director, Executive |
| Joshua Kazam | Director |
| Georg Krause Vilmar | Executive |
| Devon Kuehn | Executive |
| Anton Linderum | Director |
| Niall Mullane | Executive |
| Guy Oranim | Director |
| Robert Peruzzi | Executive |
| Amy Schulman | Director |
| Allan Sebbag | Executive |
| Denice Torres | Director |
| Michael Tully | Director |
| Saloni Varma | Executive |
| Raphael Wallander | Director |
| Hemi Zucker | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:New York, NY, 10013